AI Monitoring for Pharmacovigilance: How Drug Companies Track Mentions Before Regulators Do
The standard pharmacovigilance process has a timing problem Adverse events travel faster than case reports. A patient posts about a […]
The standard pharmacovigilance process has a timing problem Adverse events travel faster than case reports. A patient posts about a […]
A compliance primer for Medical Affairs, Regulatory Affairs, Pharmacovigilance, and Brand teams The Short Answer Neither FDA nor EMA has
Real Chemistry billed HealthGEO, launched on August 21, 2025, as the industry’s first healthcare-specific generative engine optimization (GEO) intelligence platform
By 2002, an estimated 94% of gabapentin prescriptions were written for conditions the drug was never approved to treat [6].
In May 2026, 5W AI Communications ran more than 60 patient and consumer prompts against ChatGPT, Claude, Perplexity, Gemini, and
The short answer: Twenty brand and generic names dominate AI-monitoring query volume tracked across consumer and clinical assistants: Lipitor, Advil,
In January 2026, Hims & Hers launched a compounded oral semaglutide pill priced at $49 for the first month. Nine
Patients don’t usually get into trouble because they don’t care. They get into trouble because the real world is messy:
There are two kinds of medication confusion. The harmless kind—where someone mixes up a dose or forgets a detail. And
There’s a particular kind of confidence that comes from hearing someone else say, “You don’t really need to taper—just stop.”
Top OTC vs prescription overlap mistakes (people accidentally doubling up) There are two kinds of medication problems: the ones you
About a third of US adults now ask an AI chatbot a health question in a given year, roughly the
Sign in or create a free account to read this DrugChatter article